Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Communications|August 29, 2018
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant miceMarcela P Cataldi, Peijuan Lu, Anthony Blaeser, et al.
Molecular Therapy. Methods & Clinical Development|January 29, 2020
ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant MiceMarcela P Cataldi, Anthony Blaeser, Peijuan Lu, et al.
Neuromuscular Disorders : NMD|May 5, 2015
Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacityHiroyuki Awano, Anthony Blaeser, Bo Wu, et al.
Human Genetics|April 18, 2013
Mouse models of fukutin-related protein mutations show a wide range of disease phenotypesAnthony Blaeser, Elizabeth Keramaris, Yiumo M Chan, et al.
The American Journal of Pathology|May 16, 2015
Restoration of Functional Glycosylation of α-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle RegenerationHiroyuki Awano, Anthony Blaeser, Elizabeth Keramaris, et al.
Plos One|August 20, 2025
Ribitol treatment rescues dystroglycanopathy mice with common L276I mutationBo Wu, Pei Juan Lu, Morgan Drains, et al.
Pageof 2